Global Neuroblastoma Drugs Market Growth (Status and Outlook) 2023-2029

March 2023 | 86 pages | ID: GA9A3B2DF35EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.

LPI (LP Information)' newest research report, the “Neuroblastoma Drugs Industry Forecast” looks at past sales and reviews total world Neuroblastoma Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuroblastoma Drugs sales for 2023 through 2029. With Neuroblastoma Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuroblastoma Drugs industry.

This Insight Report provides a comprehensive analysis of the global Neuroblastoma Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuroblastoma Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuroblastoma Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuroblastoma Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuroblastoma Drugs.

The global Neuroblastoma Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Neuroblastoma Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neuroblastoma Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neuroblastoma Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neuroblastoma Drugs players cover Pfizer, Teva Pharmaceutical, Johnson & Johnson, Bristol-Myers Squibb and United Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuroblastoma Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Chemotherapy
• Immunotherapy
• Others

Segmentation by application

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Teva Pharmaceutical
• Johnson & Johnson
• Bristol-Myers Squibb
• United Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neuroblastoma Drugs Market Size 2018-2029
  2.1.2 Neuroblastoma Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Neuroblastoma Drugs Segment by Type
  2.2.1 Chemotherapy
  2.2.2 Immunotherapy
  2.2.3 Others
2.3 Neuroblastoma Drugs Market Size by Type
  2.3.1 Neuroblastoma Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
2.4 Neuroblastoma Drugs Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Neuroblastoma Drugs Market Size by Application
  2.5.1 Neuroblastoma Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)

3 NEUROBLASTOMA DRUGS MARKET SIZE BY PLAYER

3.1 Neuroblastoma Drugs Market Size Market Share by Players
  3.1.1 Global Neuroblastoma Drugs Revenue by Players (2018-2023)
  3.1.2 Global Neuroblastoma Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Neuroblastoma Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEUROBLASTOMA DRUGS BY REGIONS

4.1 Neuroblastoma Drugs Market Size by Regions (2018-2023)
4.2 Americas Neuroblastoma Drugs Market Size Growth (2018-2023)
4.3 APAC Neuroblastoma Drugs Market Size Growth (2018-2023)
4.4 Europe Neuroblastoma Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Neuroblastoma Drugs Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Neuroblastoma Drugs Market Size by Country (2018-2023)
5.2 Americas Neuroblastoma Drugs Market Size by Type (2018-2023)
5.3 Americas Neuroblastoma Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neuroblastoma Drugs Market Size by Region (2018-2023)
6.2 APAC Neuroblastoma Drugs Market Size by Type (2018-2023)
6.3 APAC Neuroblastoma Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Neuroblastoma Drugs by Country (2018-2023)
7.2 Europe Neuroblastoma Drugs Market Size by Type (2018-2023)
7.3 Europe Neuroblastoma Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neuroblastoma Drugs by Region (2018-2023)
8.2 Middle East & Africa Neuroblastoma Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Neuroblastoma Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEUROBLASTOMA DRUGS MARKET FORECAST

10.1 Global Neuroblastoma Drugs Forecast by Regions (2024-2029)
  10.1.1 Global Neuroblastoma Drugs Forecast by Regions (2024-2029)
  10.1.2 Americas Neuroblastoma Drugs Forecast
  10.1.3 APAC Neuroblastoma Drugs Forecast
  10.1.4 Europe Neuroblastoma Drugs Forecast
  10.1.5 Middle East & Africa Neuroblastoma Drugs Forecast
10.2 Americas Neuroblastoma Drugs Forecast by Country (2024-2029)
  10.2.1 United States Neuroblastoma Drugs Market Forecast
  10.2.2 Canada Neuroblastoma Drugs Market Forecast
  10.2.3 Mexico Neuroblastoma Drugs Market Forecast
  10.2.4 Brazil Neuroblastoma Drugs Market Forecast
10.3 APAC Neuroblastoma Drugs Forecast by Region (2024-2029)
  10.3.1 China Neuroblastoma Drugs Market Forecast
  10.3.2 Japan Neuroblastoma Drugs Market Forecast
  10.3.3 Korea Neuroblastoma Drugs Market Forecast
  10.3.4 Southeast Asia Neuroblastoma Drugs Market Forecast
  10.3.5 India Neuroblastoma Drugs Market Forecast
  10.3.6 Australia Neuroblastoma Drugs Market Forecast
10.4 Europe Neuroblastoma Drugs Forecast by Country (2024-2029)
  10.4.1 Germany Neuroblastoma Drugs Market Forecast
  10.4.2 France Neuroblastoma Drugs Market Forecast
  10.4.3 UK Neuroblastoma Drugs Market Forecast
  10.4.4 Italy Neuroblastoma Drugs Market Forecast
  10.4.5 Russia Neuroblastoma Drugs Market Forecast
10.5 Middle East & Africa Neuroblastoma Drugs Forecast by Region (2024-2029)
  10.5.1 Egypt Neuroblastoma Drugs Market Forecast
  10.5.2 South Africa Neuroblastoma Drugs Market Forecast
  10.5.3 Israel Neuroblastoma Drugs Market Forecast
  10.5.4 Turkey Neuroblastoma Drugs Market Forecast
  10.5.5 GCC Countries Neuroblastoma Drugs Market Forecast
10.6 Global Neuroblastoma Drugs Forecast by Type (2024-2029)
10.7 Global Neuroblastoma Drugs Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Neuroblastoma Drugs Product Offered
  11.1.3 Pfizer Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Teva Pharmaceutical
  11.2.1 Teva Pharmaceutical Company Information
  11.2.2 Teva Pharmaceutical Neuroblastoma Drugs Product Offered
  11.2.3 Teva Pharmaceutical Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Teva Pharmaceutical Main Business Overview
  11.2.5 Teva Pharmaceutical Latest Developments
11.3 Johnson & Johnson
  11.3.1 Johnson & Johnson Company Information
  11.3.2 Johnson & Johnson Neuroblastoma Drugs Product Offered
  11.3.3 Johnson & Johnson Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Johnson & Johnson Main Business Overview
  11.3.5 Johnson & Johnson Latest Developments
11.4 Bristol-Myers Squibb
  11.4.1 Bristol-Myers Squibb Company Information
  11.4.2 Bristol-Myers Squibb Neuroblastoma Drugs Product Offered
  11.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Bristol-Myers Squibb Main Business Overview
  11.4.5 Bristol-Myers Squibb Latest Developments
11.5 United Therapeutics
  11.5.1 United Therapeutics Company Information
  11.5.2 United Therapeutics Neuroblastoma Drugs Product Offered
  11.5.3 United Therapeutics Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 United Therapeutics Main Business Overview
  11.5.5 United Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neuroblastoma Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Immunotherapy
Table 4. Major Players of Others
Table 5. Neuroblastoma Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Neuroblastoma Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Table 8. Neuroblastoma Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Neuroblastoma Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Table 11. Global Neuroblastoma Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Neuroblastoma Drugs Revenue Market Share by Player (2018-2023)
Table 13. Neuroblastoma Drugs Key Players Head office and Products Offered
Table 14. Neuroblastoma Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Neuroblastoma Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Neuroblastoma Drugs Market Size Market Share by Regions (2018-2023)
Table 19. Global Neuroblastoma Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Neuroblastoma Drugs Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Neuroblastoma Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Neuroblastoma Drugs Market Size Market Share by Country (2018-2023)
Table 23. Americas Neuroblastoma Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Table 25. Americas Neuroblastoma Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Table 27. APAC Neuroblastoma Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Neuroblastoma Drugs Market Size Market Share by Region (2018-2023)
Table 29. APAC Neuroblastoma Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Table 31. APAC Neuroblastoma Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Table 33. Europe Neuroblastoma Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Neuroblastoma Drugs Market Size Market Share by Country (2018-2023)
Table 35. Europe Neuroblastoma Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Table 37. Europe Neuroblastoma Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Neuroblastoma Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Neuroblastoma Drugs Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Neuroblastoma Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Neuroblastoma Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Neuroblastoma Drugs
Table 46. Key Market Challenges & Risks of Neuroblastoma Drugs
Table 47. Key Industry Trends of Neuroblastoma Drugs
Table 48. Global Neuroblastoma Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Neuroblastoma Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Neuroblastoma Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Neuroblastoma Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Neuroblastoma Drugs Area Served and Its Competitors
Table 53. Pfizer Neuroblastoma Drugs Product Offered
Table 54. Pfizer Neuroblastoma Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Teva Pharmaceutical Details, Company Type, Neuroblastoma Drugs Area Served and Its Competitors
Table 58. Teva Pharmaceutical Neuroblastoma Drugs Product Offered
Table 59. Teva Pharmaceutical Main Business
Table 60. Teva Pharmaceutical Neuroblastoma Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Teva Pharmaceutical Latest Developments
Table 62. Johnson & Johnson Details, Company Type, Neuroblastoma Drugs Area Served and Its Competitors
Table 63. Johnson & Johnson Neuroblastoma Drugs Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Neuroblastoma Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Johnson & Johnson Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Neuroblastoma Drugs Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Neuroblastoma Drugs Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Neuroblastoma Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. United Therapeutics Details, Company Type, Neuroblastoma Drugs Area Served and Its Competitors
Table 73. United Therapeutics Neuroblastoma Drugs Product Offered
Table 74. United Therapeutics Main Business
Table 75. United Therapeutics Neuroblastoma Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. United Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Neuroblastoma Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuroblastoma Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Neuroblastoma Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Neuroblastoma Drugs Sales Market Share by Country/Region (2022)
Figure 8. Neuroblastoma Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Neuroblastoma Drugs Market Size Market Share by Type in 2022
Figure 10. Neuroblastoma Drugs in Hospitals
Figure 11. Global Neuroblastoma Drugs Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Neuroblastoma Drugs in Clinics
Figure 13. Global Neuroblastoma Drugs Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Neuroblastoma Drugs in Others
Figure 15. Global Neuroblastoma Drugs Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Neuroblastoma Drugs Market Size Market Share by Application in 2022
Figure 17. Global Neuroblastoma Drugs Revenue Market Share by Player in 2022
Figure 18. Global Neuroblastoma Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Neuroblastoma Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Neuroblastoma Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Neuroblastoma Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Neuroblastoma Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Neuroblastoma Drugs Value Market Share by Country in 2022
Figure 24. United States Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Neuroblastoma Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Neuroblastoma Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Neuroblastoma Drugs Market Size Market Share by Application in 2022
Figure 31. China Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Neuroblastoma Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Neuroblastoma Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Neuroblastoma Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Neuroblastoma Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Neuroblastoma Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Neuroblastoma Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Neuroblastoma Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Neuroblastoma Drugs Market Size Market Share Forecast by Application (2024-2029)